|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0011849,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0168273,
umls-concept:C0220825,
umls-concept:C0392756,
umls-concept:C0522523,
umls-concept:C0936012,
umls-concept:C0939677,
umls-concept:C1522318,
umls-concept:C1524063,
umls-concept:C1554078,
umls-concept:C1948041,
umls-concept:C2827664
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-6-20
|
|
pubmed:abstractText |
The objective of this study was to confirm that the efficacy and safety of percutaneous coronary intervention (PCI) in diabetic patients are not compromised by a bivalirudin-based antithrombotic strategy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
pubmed-author:BittlJohn AJA,
pubmed-author:FeitFrederickF,
pubmed-author:GurmHitinder SHS,
pubmed-author:HarringtonRobert ARA,
pubmed-author:KereiakesDean JDJ,
pubmed-author:KleimanNealN,
pubmed-author:LincoffA MichaelAM,
pubmed-author:SarembockIan JIJ,
pubmed-author:TopolEric JEJ,
pubmed-author:WilcoxRobertR,
pubmed-author:WolskiKathyK,
pubmed-author:YoungJohn JJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1932-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15963389-Aged,
pubmed-meshheading:15963389-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15963389-Anticoagulants,
pubmed-meshheading:15963389-Coronary Artery Disease,
pubmed-meshheading:15963389-Diabetes Mellitus, Type 2,
pubmed-meshheading:15963389-Double-Blind Method,
pubmed-meshheading:15963389-Female,
pubmed-meshheading:15963389-Heparin,
pubmed-meshheading:15963389-Hirudins,
pubmed-meshheading:15963389-Humans,
pubmed-meshheading:15963389-Male,
pubmed-meshheading:15963389-Middle Aged,
pubmed-meshheading:15963389-Peptide Fragments,
pubmed-meshheading:15963389-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15963389-Recombinant Proteins,
pubmed-meshheading:15963389-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
